Kynam Capital Management, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

Filing Manager
Kynam Capital Management, LP
Reporting Manager
Kynam Capital Management, LP
Security
Celldex Therapeutics, Inc. Common Stock, par value $0.001
Symbol
CLDX
Shares outstanding
66,372,307 shares
Disclosed Ownership
5,064,207 shares
Ownership
7.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:16:09 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kynam Capital Management, LP 7.6% 5,064,207 0 5,064,207 Yue Tang Managing Member
Kynam Capital Management GP, LLC 7.6% 5,064,207 0 5,064,207 Yue Tang Managing Member
Yue Tang 7.6% 5,064,207 0 5,064,207 Yue Tang Self